All Stories

  1. Regulation of PBP2x Surface Localization by aliD and clpL Alters β-Lactam Resistance in Pneumococcus
  2. Engineered antibodies bypass bacterial immune evasion to drive complement-mediated protection against lethal infections
  3. Oligopeptide Transporters of Nonencapsulated Streptococcus pneumoniae Regulate CbpAC and PspA Expression and Reduce Complement-Mediated Clearance
  4. If Not Now, When? Nonserotype Pneumococcal Protein Vaccines
  5. Prophylactic Inhibition of Colonization by Streptococcus pneumoniae with the Secondary Bile Acid Metabolite Deoxycholic Acid
  6. Prophylactic inhibition of colonization by Streptococcus pneumoniae with the secondary bile acid metabolite deoxycholic acid
  7. Otitis Media and Ear Infections: Bacteria
  8. Hydrogen Peroxide Production by Streptococcus pneumoniae Results in Alpha-hemolysis by Oxidation of Oxy-hemoglobin to Met-hemoglobin
  9. Hydrogen peroxide production by Streptococcus pneumoniae results in alpha-hemolysis by oxidation of oxy-hemoglobin to met-hemoglobin
  10. Mucosal Vaccines for Streptococcus pneumoniae
  11. The Modified Surface Killing Assay Distinguishes between Protective and Nonprotective Antibodies to PspA
  12. Selective pressure: Rise of the nonencapsulated pneumococcus
  13. Pulmonary Disease Associated With Nonencapsulated Streptococcus pneumoniae
  14. Pseudomonas aeruginosa and Streptococcus pneumoniae coinfection
  15. Invasive Potential of Nonencapsulated Streptococcus pneumoniae
  16. Polyamine transporter potABCD is required for virulence of encapsulated but not nonencapsulated Streptococcus pneumoniae
  17. Should Pneumococcal Vaccines Eliminate Nasopharyngeal Colonization?
  18. Surface Proteins and Pneumolysin of Encapsulated and Nonencapsulated Streptococcus pneumoniae Mediate Virulence in a Chinchilla Model of Otitis Media
  19. NonencapsulatedStreptococcus pneumoniae: Emergence and Pathogenesis
  20. Nonencapsulated Streptococcus pneumoniae as a cause of chronic adenoiditis
  21. Immunization with Pneumococcal Surface Protein K of Nonencapsulated Streptococcus pneumoniae Provides Protection in a Mouse Model of Colonization
  22. Nonencapsulated Streptococcus pneumoniae Cause Acute Otitis Media in the Chinchilla That Is Enhanced by Pneumococcal Surface Protein K
  23. Choline-Binding Proteins
  24. Draft Genome Sequences of Five Multilocus Sequence Types of Nonencapsulated Streptococcus pneumoniae
  25. The Cholesterol-Dependent Cytolysin Pneumolysin from Streptococcus pneumoniae Binds to Lipid Raft Microdomains in Human Corneal Epithelial Cells
  26. Serine Protease PKF of Acinetobacter baumannii Results in Serum Resistance and Suppression of Biofilm Formation
  27. PspK of Streptococcus pneumoniae Increases Adherence to Epithelial Cells and Enhances Nasopharyngeal Colonization
  28. 66-P
  29. Active Immunization with Pneumolysin versus 23-Valent Polysaccharide Vaccine for Streptococcus pneumoniae Keratitis
  30. Serum resistance and biofilm formation in clinical isolates ofAcinetobacter baumannii
  31. Cross-Sectional Study of Nasopharyngeal Carriage of Streptococcus pneumoniae in Human Immunodeficiency Virus-Infected Adults in the Conjugate Vaccine Era
  32. Protection from Streptococcus pneumoniae Keratitis by Passive Immunization with Pneumolysin Antiserum
  33. Factor H Binding to PspC of Streptococcus pneumoniae Increases Adherence to Human Cell Lines In Vitro and Enhances Invasion of Mouse Lungs In Vivo
  34. Characterization of Streptococcus pneumoniae isolated from children with otitis media
  35. Immunization with PspA Incorporated into a Poly(Ethylene Oxide) Matrix Elicits Protective Immunity against Streptococcus pneumoniae
  36. Localization of PcsB of Streptococcus pneumoniae and Its Differential Expression in Response to Stress
  37. The genetic background of Streptococcus pneumoniae affects protection in mice immunized with PspA
  38. Gene expression profiling of the response of Streptococcus pneumoniae to penicillin
  39. Tex, a putative transcriptional accessory factor, is involved in pathogen fitness in Streptococcus pneumoniae
  40. Interaction of clinical isolates of Streptococcus pneumoniae with human complement factor H
  41. 57-P
  42. In Vivo Binding of Complement Regulator Factor H by Streptococcus pneumoniae
  43. THP-1 Monocytes Up-Regulate Intercellular Adhesion Molecule 1 in Response to Pneumolysin from Streptococcus pneumoniae
  44. Impact of peripheral blood IL-18 gene early expression on kidney allograft long-term outcome
  45. Dual Roles of PspC, a Surface Protein of Streptococcus pneumoniae, in Binding Human Secretory IgA and Factor H
  46. Pneumococcal Disease
  47. Relative Roles of Genetic Background and Variation in PspA in the Ability of Antibodies to PspA To Protect against Capsular Type 3 and 4 Strains of Streptococcus pneumoniae
  48. Pneumolysin-Dependent and -Independent Gene Expression Identified by cDNA Microarray Analysis of THP-1 Human Mononuclear Cells Stimulated by Streptococcus pneumoniae
  49. Genetic Immunization with the Region Encoding the α-Helical Domain of PspA Elicits Protective Immunity againstStreptococcus pneumoniae
  50. Immunization with a plasmid expressing pneumococcal surface protein A (PspA) can elicit protection against fatal infection with Streptococcus pneumoniae
  51. Oligonucleotides identify conserved and variable regions of pspA and pspA-like sequences of Streptococcus pneumoniae
  52. Evidence for the simultaneous expression of two PspAs by a clone of capsular serotype 6BStreptococcus pneumoniae
  53. Truncated Streptococcus pneumoniae PspA Molecules Elicit Cross-Protective Immunity against Pneumococcal Challenge in Mice
  54. Localization of protection-eliciting epitopes on PspA of Streptococcus pneumoniae between amino acid residues 192 and 260
  55. Molecular localization of variable and conserved regions of pspA and identification of additional pspA homologous sequences in Streptococcus pneumoniae
  56. Variation in the molecular weight of PspA (pneumococcal surface protein A) among Streptococcus pneumoniae
  57. Protein serotyping of Streptococcus pneumoniae based on reactivity to six monoclonal antibodies
  58. Role of Pneumococcal Surface Protein A in the Virulence of Streptococcus pneumoniae
  59. Analysis of a surface protein of Streptococcus pneumoniae recognised by protective monoclonal antibodies
  60. Monoclonal Antibodies against Surface Components of Streptococcus pneumoniae
  61. Monoclonal antibodies against protease-sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae